MergerLinks Header Logo

Submit Deal

Submit Deal

Announced

Completed

Maravai LifeSciences completed the acquisition of Alphazyme.

Synopsis

Maravai LifeSciences, a life sciences company providing critical products to enable the development of drug therapies, diagnostics, novel vaccines, completed the acquisition of Alphazyme, an OEM provider of custom, scalable molecular biology enzymes. Financial terms were not disclosed.

Principals

Alphazyme

target

Alphazyme

Maravai Lifesciences

bidder

Maravai Lifesciences

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Dealmakers (4)

Service Providers

Sort

Christopher Benoit

Christopher Benoit

ManagerCEO at ALPHAZYME LLC
Deal Bio
Total Deals
1/
Total Value
value n/a
Carl Hull

Carl Hull

ManagerChairman and CEO at MARAVAI LIFESCIENCES INC
Deal Bio
Total Deals
4/
Total Value
£179M
Justin Sun

Justin Sun

Financial AdvisorRothschild & Co
Deal Bio
Total Deals
2/
Total Value
value n/a
Timothy Hotchandani

Timothy Hotchandani

Financial AdvisorManaging Director at Rothschild & Co
Deal Bio
Total Deals
11/
Total Value
£4,653M

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US